Zhejiang Charioteer Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PENCICLOVIR (API), with a corresponding US DMF Number 30758.
Remarkably, this DMF maintains an Active status since its submission on July 30, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 30, 2016, and payment made on August 05, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II